We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
-9.28%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$159M
AUM Growth
-$22.6M
Cap. Flow
+$44.4K
Cap. Flow %
0.03%
Top 10 Hldgs %
87.32%
Holding
43
New
5
Increased
6
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
AVXL icon
Anavex Life Sciences
AVXL
+$2.59M
2
SPRO icon
Spero Therapeutics
SPRO
+$717K
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$511K
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$499K
5
AEM icon
Agnico Eagle Mines
AEM
+$460K

Top Sells

Rank Stock Value
1
BX icon
Blackstone
BX
+$976K
2
AMD icon
Advanced Micro Devices
AMD
+$495K
3
KL
Kirkland Lake Gold Ltd Ordinary
KL
+$451K
4
SNGX icon
Soligenix
SNGX
+$111K

Sector Composition

Rank Sector Weight
1 Healthcare 86.23%
2 Materials 3.35%
3 Technology 2.92%
4 Financials 1.93%
5 Industrials 1.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$107M 67.04%
900,844
+4,000
+0.4% +$499K
ENTX icon
2
Entera Bio
ENTX
$101M
$7.13M 4.47%
2,484,275
– –
EIGR
3
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$5.76M 3.62%
23,141
– –
ALDX icon
4
Aldeyra Therapeutics
ALDX
$91.7M
$3.38M 2.12%
759,405
– –
CRBP icon
5
Corbus Pharmaceuticals
CRBP
$170M
$2.68M 1.68%
168,196
– –
AVXL icon
6
Anavex Life Sciences
AVXL
$222M
$2.6M 1.63%
+210,789
New +$2.59M
APLT
7
DELISTED
Applied Therapeutics
APLT
$2.28M 1.43%
1,082,123
+50,000
+5% +$134K
BX icon
8
Blackstone
BX
$104B
$2.01M 1.26%
16,000
-8,000
-33% -$976K
ANET icon
9
Arista Networks
ANET
$219B
$1.92M 1.2%
55,200
– –
CVS icon
10
CVS Health
CVS
$137B
$1.46M 0.92%
14,500
– –
TMO icon
11
Thermo Fisher Scientific
TMO
$211B
$1.24M 0.78%
2,100
– –
MO icon
12
Altria Group
MO
$122B
$1.19M 0.74%
22,700
– –
BAH icon
13
Booz Allen Hamilton
BAH
$8.7B
$1.14M 0.72%
13,000
– –
LUMN icon
14
Lumen
LUMN
$6.53B
$1.13M 0.71%
100,000
– –
V icon
15
Visa
V
$677B
$1.07M 0.67%
4,850
– –
GLW icon
16
Corning
GLW
$126B
$982K 0.62%
26,600
– –
AEM icon
17
Agnico Eagle Mines
AEM
$72.6B
$943K 0.59%
15,393
+8,493
+123% +$460K
AMD icon
18
Advanced Micro Devices
AMD
$851B
$897K 0.56%
8,200
-4,150
-34% -$495K
ASML icon
19
ASML
ASML
$675B
$855K 0.54%
1,280
– –
OSK icon
20
Oshkosh
OSK
$9.67B
$850K 0.53%
8,450
– –
ALT icon
21
Altimmune
ALT
$539M
$810K 0.51%
132,978
– –
ABEO icon
22
Abeona Therapeutics
ABEO
$345M
$709K 0.45%
88,630
– –
OR icon
23
OR Royalties Inc
OR
$5.47B
$612K 0.38%
190,000
– –
SPRO icon
24
Spero Therapeutics
SPRO
$68.9M
$609K 0.38%
+70,000
New +$717K
FNV icon
25
Franco-Nevada
FNV
$41.4B
$598K 0.38%
3,750
– –
1
2

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Knoll Capital Management held 43 positions worth $159M, down 12% from $182M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Knoll Capital Management's Q1 2022 filing shows 5 new, 6 increased, 3 reduced and 2 closed positions. Its largest new stake was Anavex Life Sciences: 210,789 shares worth $2.6M. The largest sale was Blackstone, an estimated $976K.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 86% a quarter earlier, followed by Materials and Technology.

  • Knoll Capital Management's largest Q1 2022 buy was Anavex Life Sciences: 210,789 shares worth $2.6M.
  • Knoll Capital Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q1 2022, an estimated $499K increase.
  • Knoll Capital Management's biggest Q1 2022 reduction was Blackstone, cutting an estimated $976K.
  • Knoll Capital Management fully exited Kirkland Lake Gold Ltd Ordinary in Q1 2022, selling an estimated $451K.
  • Knoll Capital Management's ten largest holdings make up 87% of its $159M portfolio in Q1 2022.
  • Knoll Capital Management opened 5 new positions and closed 2 in Q1 2022.
  • Knoll Capital Management's portfolio value fell 12% quarter-over-quarter to $159M.

Based on Knoll Capital Management's 13F filing for Q1 2022, filed 16 May 2022.